SCHEMBL25112736

SCHEMBL25112736

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccccc3-c3ccccc3-c3cc4ccc5cccc6c7cccc8ccc9cccc(c(c3)c4c56)c9c87)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.42
ERBB2 P04626 1/20 0.42
FYN P06241 1/20 0.42
MAOA P21397 1/20 0.42
ACHE P22303 1/20 0.42
AHR P35869 1/20 0.42
ALDH1A1 P00352 7/20 0.42
HSD17B10 Q99714 5/20 0.42
HPGD P15428 5/20 0.42
THRB P10828 1/20 0.42
TSHR P16473 4/20 0.39
L3MBTL1 Q9Y468 4/20 0.39
MAPT P10636 4/20 0.39
KDM4E B2RXH2 4/20 0.39
MAPK1 P28482 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
ATM Q13315 3/20 0.39
TP53 P04637 2/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25112731 0.97 CYP1A2 (0.41) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL25112738 0.95 ALDH1A1 (0.40) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL25112735 0.95 CYP1A2 (0.39) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL25112610 0.94 ALDH1A1 (0.43) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL25112627 0.93 CYP1A2 (0.40) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL25112611 0.93 ALDH1A1 (0.40) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL25112700 0.91 CYP1A2 (0.40) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL25112628 0.90 CYP1A2 (0.44) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL25112694 0.89 ALDH1A1 (0.41) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL25112590 0.89 ALDH1A1 (0.43) CYP1A2ERBB2FYNMAOAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230085328-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-03-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230085328-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE L1CAM, PIEZO1, LEF1 CYP1A2 1265/4885ERBB2 3766/4885FYN 2545/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.